Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 22, 2026Expert Opinion on Drug Discovery

Leveraging Molecular Dynamics Simulations to Study Psychedelics and Their Receptors in Future Drug Development

View Full Paper
Ask AI
Bookmark
Share

Authors

MZM. ZhangPJPu JiangYWYibo Wang

Discussion

Loading...

Member takes

Overview

Leveraging molecular dynamics simulations enhances drug design for psychedelics, promising safer clinical candidates.

Key Points

  • This research aims to enhance psychedelic drug discovery using molecular dynamics simulations for precision design.
  • Utilized molecular dynamics (MD) simulations to model interactions between psychedelics and their receptors.
  • Conducted in silico screening of compounds to optimize lead candidates selectively.
  • Integrated AI-refined force fields and structural modeling for receptor complexes.
  • Coupled MD simulations with kinetic pharmacology to assess drug effectiveness.
  • Demonstrated accelerated lead optimization through simulation techniques.
  • Highlighted potential for more precise drug candidates by closing the translational gap into in vivo studies.
  • Outlined a vision for a cloud-based MD platform aimed at standardizing drug screening in five years.

Cite This Study

Zhang et al. (2026) studied this question.

synapsesocial.com/papers/69bf8692f665edcd009e8e79https://doi.org/10.1080/17460441.2026.2649897
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Molecular Dynamics Simulations in Modern Medicinal Chemistry2026
  2. 2Molecular dynamics simulations and drug discovery2011 · 1,426 citations
  3. 3Molecular Modeling of the Pathogenetic Mechanisms of Neuropsychiatric Disorders2026
  4. 4Integrative Computational Chemistry Approaches in Modern Drug Discovery: Advances in Docking, Pharmacophore Modeling, Molecular Dynamics, and Virtual Screening2026 · 3 citations
  5. 5Strategic Neurodelivery of Psychedelic Compounds: Bridging MolecularPharmacology with Therapeutic Innovation in CNS Disorders2026